Synovial Final2

download Synovial Final2

of 24

Transcript of Synovial Final2

  • 7/28/2019 Synovial Final2

    1/24

  • 7/28/2019 Synovial Final2

    2/24

    I. Physiology & Composition Movable joints (diarthroses) composed of: Bones lined with articular cartilage

    Separated by a cavity containing synovial fluid enclosed in asynovial membrane

    Synovial membrane

    synoviocytes: Phagocyticsynthesizes degradative enzymes

    Synthesizes hyaluronate

    Connective tissue Blood vessels, lymphatics & nerves

    Fluid formation Ultrafiltrate of plasma across synovial membrane Non selective

    Excludes proteins of high molecular weight

    Synoviocytes Secrete mucopolysaccharite which contains:

    Hyaluronic acid

    protein

  • 7/28/2019 Synovial Final2

    3/24

    Cartilage & fluid function: Reduce friction between bones Lubricates joints Fluid provides nutrients to cartilage

    Lessens shock of walking and jogging impactSynovial Fluid Normal ValuesVolume

  • 7/28/2019 Synovial Final2

    4/24

    Collection: arthrocentesisneedle aspiration ofsynovial fluid

    Volume: Normal= 3.5 mL

    Diseased / inflamed = up to 25 mL

    Collect 2 tubes Heparin tube : microbiology

    Plain top: chemistry and immunology EDTA (liquid) : hematology

    *Avoid all powdered anticoagulantsinterfere with crystalanalysis

    Fluid verification

    Mucin clot test- Add fluid to dilute acetic acid turbidity (clot formation) due

    to hyaluronate

    Metachromatic staining Place fluid on filter paper + few drops of toluidine blue

    metachromatic staining

  • 7/28/2019 Synovial Final2

    5/24

    Color: Normalclear, pale yellow

    Red to brown: indicates trauma of procedure ordisorder Turbidity: associated with presence of WBCs Milky: may indicate presence of crystals

    Viscosity:

    Measured at bedside by ability to form a string from tipof syringeNormal: 4-6 cm

    Ropes test (mucin clot test)measurement ofhyaluronate polymerizationFluid forms a clot surrounded by clear fluid when added to

    acetic acidClot quality is reported:Good = solid clot

    Fair = soft clot

    Poor = friable clot

    Very poor = no clot

    Test is of questionable precision and seldom used

  • 7/28/2019 Synovial Final2

    6/24

  • 7/28/2019 Synovial Final2

    7/24

    Cell CountWBCs Method

    Use Neubauer counting chamber May pretreat viscous fluids with hyaluronidase & incubate

    at 37oC for 5 min. Dilution with hypotonic saline is used to lyse any RBCs OR Dilute with normal saline/methylene blue mixture to

    differentiate WBCs from RBCs

    Normal =

  • 7/28/2019 Synovial Final2

    8/24

    Other cell abnormalities: Increased eosinophilsrheumatic fever, parasitic

    infections, metastatic carcinoma, post radiationtherapy or arthrography

    LE cellspatients with lupus erythematosus

    Reiter cellsmacrophages with ingested neutrophils

    RA cells (ragocytes)precipitated rheumatoid factor

    appearing as cytoplasmic granules in neutrophils

    Hemosiderin granulesdue to hemorrhagic process

    or cases of pigmented villonodular synovitis

    Cartilaginous cellsobserved in cases of osteoarthritis

    Rice bodiesfound in septic and rheumatoid arthritisand Tuberculosis

    Fat dropletsindicate traumatic injury

  • 7/28/2019 Synovial Final2

    9/24

    Synovial lining cell

  • 7/28/2019 Synovial Final2

    10/24

    Neutrophils in synovial fluid

  • 7/28/2019 Synovial Final2

    11/24

    Lymphs in synovial fluid

  • 7/28/2019 Synovial Final2

    12/24

    LE cell in synovial fluid

  • 7/28/2019 Synovial Final2

    13/24

    Crystals Crystal formation may be due to: Metabolic disorders Decreased renal excretion

    Cartilage and bone degeneration Medicinal injection (ex: corticosteroids)

    Fluid is examined using the wet preparation technique ASAP examination as pH and temperature affect observation Ideally examined prior to WBC disintegration Examine under both direct and compensated polarizing light

    *may also be observed in Wright stain preparations Under polarizing light (Direct polarization) Birefringent substances appear as bright objects on a black

    background Intensity varies between substances

    Under compensated polarizing light

    A red compensator plate is placed between the crystal and slide Crystals aligned parallel to the compensator appear yellow

    (negative birefringence) Crystals aligned perpendicular to the compensator appear blue

    (positive birefringence)

    M di U t C t l (MSU)

  • 7/28/2019 Synovial Final2

    14/24

    Monosodium Urate Crystals (MSU)

    Indicate gouty arthritis due to: Increased serum uric acid

    Decreased renal excretion of uric acid

    Impaired metabolism of nucleic acid

    Exhibit negative birefringence Intracellular (acute stages) & extracellular location

    Polarized lightstrongly birefringent

    Compensated polarized lightyellow when parallel

    blue when perpendicular

    Needle shaped Calcium pyrophosphate (CCPD) Indicates pseudogout due to: Degenerative arthritis

    Endocrine disorders with increased serum calcium

    Calcification of cartilage

    Exhibit positive birefringence Seen intracellular- and extracellularly

    Polarized lightweakly birefringent

    Compensated polarized lightblue when parallel (yellow whenperpendicular)

    Blunt rods or rhombic shapes

  • 7/28/2019 Synovial Final2

    15/24

    Acute gout (uric acid crystals)

  • 7/28/2019 Synovial Final2

    16/24

    Uric acid crystals

  • 7/28/2019 Synovial Final2

    17/24

    Cholesterol

    Nonspecific indications Associated with chronic inflammation

    Exhibit negative birefringence (compensated polarized light)

    Usually seen extracellularly Polarized lightstrongly birefringence

    Rhombic plates

    Hydroxyapatite (HA) (Calcium phosphate)

    Associated with calcific deposition conditions

    May produce an acute inflammatory reaction

    Intracellular

    Not birefringent

    Require an electron microscope to examine

    Small, needle shaped

    Corticosteroid Associated with intra-articular injections; NO clinical significance

    Primarily intracellular

    Exhibit positive and negative birefringence Can closely resemble MSU and CCPD

    Flat, variable shaped plates

  • 7/28/2019 Synovial Final2

    18/24

    Calcium Oxalate

    Following renal dialysis

    Birefringent Artifacts:

    Anticoagulant crystals (calcium oxalate, lithiumheparin)

    Starch granules

    Prosthesis fragments

    Collagen fibers

    Fibrin

    Dust particles

  • 7/28/2019 Synovial Final2

    19/24

  • 7/28/2019 Synovial Final2

    20/24

    Glucose Done simultaneously with blood sample (prefer 8 hour

    fast)

    Difference between blood and synovial glucose valuesis evaluated Normal = < 10 mg/dL Inflammatory conditions = > 25mg/dL Sepsis = >40 mg/dL Considered low if < serum plasma glucose value

    Should be run within 1 hour of collection Draw in sodium fluorideprevents glycolysis

    Total protein Not routinely performed Normal = < 1/3 of serum value (~3g/dL)

    Large molecule, not easily filtered by membrane Increased protein Changes in membrane permeability Increased joint synthesis Indicates an inflammatory process

  • 7/28/2019 Synovial Final2

    21/24

    Uric Acid

    Alone, not diagnostic

    May determine gout in conjunction with plasma uric

    acid, esp. when crystals are undetectable Normal = serum level

    Lactate

    May differentiate between inflammatory and septicarthritis

    Septic arthritis = >250 mg/dL

    Gonococcal arthritis = normal to low levels

    Production results from :

    Increased demand for energy

    Tissue hypoxia Severe inflammatory conditions

  • 7/28/2019 Synovial Final2

    22/24

    Gram stain

    Performed on all specimens Most infections are bacterial:

    Staphylococcus

    Streptococcus

    S. pyogenes

    S. pneumoniae Hemophilus

    Neisseria gonorrhea

    Fungal, viral and tubercular agents may also beobserved

    Culture Routine culture

    Enrichment medium (chocolate agar

    Specialty media depending on clinician orders and

    indications

  • 7/28/2019 Synovial Final2

    23/24

    Autoantibody detection (same as

    found in serum)

    Rheumatoid arthritis (RA)

    Lupus erythematosus (LE)

    Antibody detection in patients serum

    Borrelia burgdorferi

    Causative agent of Lyme disease Cause of arthritis

  • 7/28/2019 Synovial Final2

    24/24

    Group Classification SignificanceI. Noninflammatory Degenerative joint disorders

    II. Inflammatory Immunologic problems (RA,LE)Gout&pseudogout(crystal induced)

    I. Septic Microbial infectionII. Hemorrhagic Traumatic injury

    Coagulation deficiency

    Note:

    * categories overlap* multiple conditions can occur simultaneously* disease stage can vary laboratory results

    *see text for details of associated abnormal laboratoryfindings